QAD Inc. (NASDAQ:QADA) President Pamela M. Lopker sold 683 shares of QAD stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $42.32, for a total value of $28,904.56. Following the completion of the transaction, the president now directly owns 4,467,095 shares in the company, valued at $189,047,460.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of QAD stock opened at $42.74 on Wednesday. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.18. The stock has a 50 day moving average of $42.01. The stock has a market cap of $831.23 million, a PE ratio of 83.80 and a beta of 1.12. QAD Inc. has a one year low of $38.32 and a one year high of $61.80.
QAD (NASDAQ:QADA) last announced its quarterly earnings results on Wednesday, May 29th. The software maker reported ($0.16) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.26) by $0.10. The business had revenue of $78.00 million for the quarter, compared to analysts’ expectations of $78.25 million. QAD had a return on equity of 4.81% and a net margin of 1.78%. The business’s quarterly revenue was down 9.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.06 EPS. As a group, sell-side analysts forecast that QAD Inc. will post -0.26 earnings per share for the current year.
A number of equities analysts have commented on QADA shares. B. Riley set a $55.00 price target on QAD and gave the stock a “buy” rating in a research note on Thursday, March 21st. ValuEngine cut Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Zacks Investment Research cut Hersha Hospitality Trust from a “buy” rating to a “hold” rating in a research note on Thursday, May 2nd. BidaskClub raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Thursday, July 4th. Finally, TheStreet cut Virtusa from a “b-” rating to a “c+” rating in a research note on Wednesday, May 29th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. QAD presently has a consensus rating of “Buy” and a consensus target price of $53.33.
Hedge funds have recently modified their holdings of the company. Marshall Wace North America L.P. bought a new stake in shares of QAD in the 1st quarter worth approximately $41,000. Legal & General Group Plc grew its position in shares of QAD by 32.9% in the 4th quarter. Legal & General Group Plc now owns 1,947 shares of the software maker’s stock worth $76,000 after buying an additional 482 shares during the last quarter. BNP Paribas Arbitrage SA grew its position in shares of QAD by 21,650.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 2,175 shares of the software maker’s stock worth $94,000 after buying an additional 2,165 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its position in shares of QAD by 383.0% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,492 shares of the software maker’s stock worth $137,000 after buying an additional 2,769 shares during the last quarter. Finally, Squarepoint Ops LLC grew its position in shares of QAD by 56.2% in the 4th quarter. Squarepoint Ops LLC now owns 11,874 shares of the software maker’s stock worth $467,000 after buying an additional 4,274 shares during the last quarter. Hedge funds and other institutional investors own 46.69% of the company’s stock.
QAD Company Profile
QAD Inc provides enterprise software solutions for manufacturing companies in the automotive, life sciences, consumer products, food and beverage, high technology, and industrial products industries worldwide. The company offers QAD Enterprise Applications, an integrated suite of software applications, which support the core business processes.
Featured Story: Trading Ex-Dividend
Receive News & Ratings for QAD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QAD and related companies with MarketBeat.com's FREE daily email newsletter.